Delhi seizes Rs 20 lakh insulin stock from firms violating storage norms

• Delhi Drugs Control Department seized insulin worth over Rs 20 lakh from wholesale drug firms.
• Action taken during a special enforcement drive for violating storage and regulatory norms.
• Four out of six firms inspected were found violating provisions of the Drugs and Cosmetics Act.
• 2,104 units of insulin, including Tresiba FlexTouch and Glaritus, were seized, valued at Rs 20,06,024.
• Firms failed to provide purchase records; some stored insulin at room temperature, violating cold chain.